FMS - Fresenius Medical Care AG & Co. KGaA
42.16 0.00 (0.00%)
After hours: 4:15PM EDT
Chart Events
Price Crosses Moving Average
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 41.64 |
| Open | 41.49 |
| Bid | 35.00 x 800 |
| Ask | 42.24 x 900 |
| Day's Range | 41.46 - 42.22 |
| 52 Week Range | 29.17 - 44.47 |
| Volume | 168,803 |
| Avg. Volume | 208,003 |
| Market Cap | 24.735B |
| Beta (5Y Monthly) | 1.11 |
| PE Ratio (TTM) | 11.42 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 17, 2019 |
| 1y Target Est | N/A |
Fair Value
Related Research
- Analyst Report: Fresenius Medical Care AG & Co. KGaA
- Analyst Report: Fresenius Medical Care AG & Co. KGaA
- Business Wire
Nursing the World to Health: Celebrating Fresenius Kidney Care Nurses’ Contribution in Asia Pacific on International Nurses Day
Today, on International Nurses Day, Fresenius Medical Care, the world’s leading provider of dialysis products and services, is celebrating the extraordinary contribution that its nurses make to the organization and wider community – every day, and particularly in the face of our current global health challenge.
- Business Wire
The Kidney Kid Superhero Initiative Goes International on World Kidney Day
Fresenius Medical Care, the world’s leading provider of dialysis products and services, has today announced the international and digital expansion of its highly successful Asia Pacific-wide Corporate Social Responsibility (CSR) initiative, The Kidney Kid superhero. This colorful character takes children on a series of adventures to learn more about their ‘super organ’ kidneys and how to keep them healthy. The expansion of this initiative comes on World Kidney Day, which in 2020, is calling on everyone to advocate for concrete measures in every country to promote and advance kidney disease prevention.
- ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS
NEW YORK, NY / ACCESSWIRE / November 16, 2019 / Pomerantz LLP is investigating claims on behalf of investors of Fresenius Medical Care AG & Co. KGaA ("Fresenius" or the "Company") (FMS). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. The investigation concerns whether Fresenius and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
- ACCESSWIRE
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Fresenius Medical Care AG & Co. KGaA (FMS)
NEW YORK, NY / ACCESSWIRE / October 23, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fresenius Medical Care AG & Co. KGaA ("Fresenius" ...
- PR Newswire
Global Insights and Local Promise: Fresenius Medical Care's annual medical report explores how Interconnected Intelligence is transforming healthcare
WALTHAM, Mass. , Sept. 9, 2019 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of dialysis products and services, today announced the publication of its 2019 global annual medical ...
